Sunday, July 24, 2005

Important Safety Information on Concomitant Use of PAXIL or PAXIL CR and pimozide (Orap)

From Health Canada:
The concomitant use of PAXIL® or PAXIL CR™ and pimozide (Orap®) is contraindicated as paroxetine has been shown to increase plasma pimozide levels. Elevation of pimozide blood concentration may result in QT interval prolongation and severe arrhythmias including Torsade de Pointes.

No comments: